Division of Molecular Pathology, Aichi Cancer Center

Japan

1 June 2019 - 31 May 2020

No articles found. Division of Molecular Pathology, Aichi Cancer Center did not contribute to any primary research papers from Nature Index journals in the current 12 month window.

Aichi Cancer Center

↳ Aichi Cancer Center Research Institute

↳ Division of Molecular Pathology, Aichi Cancer Center

Division of Molecular Medicine, Aichi Cancer Center

Division of Molecular Oncology, Aichi Cancer Center

Aichi Cancer Center Hospital

Department of Breast Oncology, Aichi Cancer Center

Department of Hematology and Cell Therapy, Aichi Cancer Center

Department of Pathology and Molecular Diagnostics, Aichi Cancer Center

Department of Urology, Aichi Cancer Center

Return to institution outputs

Latest supplement

Nature Index 2020 South Korea

A concerted government push to make South Korea an innovation leader, backed by strong investment and systemic reform, has brought rapid and long-lasting results. The country’s scientific landscape is becoming more diverse and more productive, as a place where upwardly mobile researchers thrive.

Access free